Advantage Trust Company’s Barclays BCS Stock Holding History

Advantage Trust Company’s Portfolio BCS Stock Details BCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-194	Closed	-$3.12K	–	154
2024 Q4	$3.12K	Buy	+194	New	+$2.51K	﹤0.01%	170

Other funds holding BCS

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Advantage Trust Company's BCS Position: Q1 2025 in Review

Advantage Trust Company sold out of Barclays (BCS) in Q1 2025, closing a stake of 194 shares — an estimated $3.12K sold.

Advantage Trust Company first reported a position in BCS in Q4 2024 and held it in 1 quarter. The position peaked at $3.12K in Q4 2024. 406 funds tracked by Wall St. Rank hold BCS as of Q1 2025.

Advantage Trust Company reported no remaining Barclays position as of Q1 2025 after selling out during the quarter.
Advantage Trust Company sold 194 Barclays shares in Q1 2025, an estimated $3.12K.
Advantage Trust Company first reported a position in Barclays in Q4 2024 and held it in 1 quarter.
Advantage Trust Company's Barclays position peaked at $3.12K in Q4 2024.
406 funds tracked by Wall St. Rank held Barclays as of Q1 2025.

Based on Advantage Trust Company's 13F filing for Q1 2025, filed 7 May 2025.